These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15496165)

  • 21. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
    Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
    Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candesartan and insulin reduce renal sympathetic nerve activity in hypertensive type 1 diabetic rats.
    Takimoto C; Kumagai H; Osaka M; Sakata K; Onami T; Kamayachi T; Iigaya K; Hayashi K; Saruta T; Itoh H
    Hypertens Res; 2008 Oct; 31(10):1941-51. PubMed ID: 19015602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of unilateral nephrectomy on renal function of diabetic rats.
    Lopes GS; Lemos CC; Mandarim-De-Lacerda CA; Bregman R
    Histol Histopathol; 2004 Oct; 19(4):1085-8. PubMed ID: 15375750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats.
    Higashi T; Kobayashi N; Hara K; Shirataki H; Matsuoka H
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):564-71. PubMed ID: 10774787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II.
    Deng A; Miracle CM; Suarez JM; Lortie M; Satriano J; Thomson SC; Munger KA; Blantz RC
    Kidney Int; 2005 Aug; 68(2):723-30. PubMed ID: 16014049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
    Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
    Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats.
    Komers R; Lindsley JN; Oyama TT; Anderson S
    Nitric Oxide; 2004 Sep; 11(2):147-55. PubMed ID: 15491847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of angiotensin II receptor antagonist olmesartan on renal hemodynamic variables and vascular structural properties in streptozotocin-induced diabetic rats.
    Song HF; Chen JF; Sun NL; Li HW
    Chin Med J (Engl); 2011 Feb; 124(4):562-7. PubMed ID: 21362282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of glomerular filtration and plasma flow in experimental diabetic rats.
    Michels LD; Davidman M; Keane WF
    J Lab Clin Med; 1981 Dec; 98(6):869-85. PubMed ID: 7031154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
    Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
    Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Kobayashi T; Shirataki H; Matsuoka H
    Atherosclerosis; 2001 Oct; 158(2):359-68. PubMed ID: 11583714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
    Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
    Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy.
    Podjarny E; Bernheim J; Hasdan G; Karsh D; Rashid G; Green J; Katz B; Bernheim J
    Nephrol Dial Transplant; 2007 Jul; 22(7):1864-72. PubMed ID: 17442743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
    Azegami T; Sasamura H; Hayashi K; Itoh H
    Hypertens Res; 2012 May; 35(5):492-9. PubMed ID: 22158111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats.
    Susic D; Zhou X; Frohlich ED
    Am J Nephrol; 2009; 29(6):639-45. PubMed ID: 19155618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
    Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
    Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.